BALA CYNWYD, PA / ACCESSWIRE / September 29, 2021 / Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of ARYA Sciences Acquisition Corp ...
NEW YORK, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims ...
As ARYA Sciences Acquisition IV (ARYD) celebrates its new 52-week high, a deeper dive into the company's financial health and stock behavior is warranted. According to InvestingPro data, ARYD's market ...
ARYD, the ticker symbol representing ARYA Sciences Acquisition IV, has recently marked a new 52-week low, with its stock price descending to $7.51. This latest price point underscores a period of ...
Adagio Medical, a company that specializes in catheter ablation technologies for the treatment of cardiac arrhythmias, said Wednesday it would go public via a merger with ARYA Sciences Acquisition ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...
ARYD SEC Filings Filing Type: Financials ARYA Sciences Acquisition Corp IV (ARYD) - 10-Q/A - Amended Quarterly Report SEC FilingsMon, May 20, 2024 ARYA Sciences Acquisition Corp IV (ARYD) - 10-Q - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results